Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methods of treating C5 mediated complement-associated conditions with anti-C5 antibodies having improved pharmacokinetics

Methods of treating C5 mediated complement-associated conditions with anti-C5 antibodies having improved pharmacokinetics

US Patent 9107861 · Granted Aug 18, 2015

Estimated economic value: $275,711,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Monovalent anti-properdin antibodies and antibody fragments2025
Monovalent anti-properdin antibodies and antibody fragments2025
Subcutaneous dosage and administration of anti-C5 antibodies for treatment of pa2025
Polypeptides that bind complement component C5 or serum albumin and fusion prote2025
Polypeptides that bind complement component C5 or serum albumin and fusion prote2025
Method of quantitating unbound C5 in a sample2024
Humanized anti-CD200 antibodies and uses thereof2023
Polypeptides that bind complement component C5 or serum albumin and fusion prote2022
Polypeptides that bind complement component C5 or serum albumin and fusion prote2022
Anti-C5 antibodies having improved pharmacokinetics2022
Anti-C5 antibodies having improved pharmacokinetics2022
Anti-C5 antibodies having improved pharmacokinetics2022